SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Buying IPOs on the open market -- Ignore unavailable to you. Want to Upgrade?


To: J Gunn who wrote (5144)12/10/1999 12:44:00 AM
From: J Gunn  Read Replies (2) | Respond to of 5529
 
Is there anyone on this board that has been issued IPO shares under a Friends and Family situation?

Can anyone explain the mechanics of how the shares are credited to your account? Are they there before the market opens so you can issue a sell order against them?



To: J Gunn who wrote (5144)12/10/1999 1:20:00 AM
From: Jim B  Read Replies (2) | Respond to of 5529
 
nice writeup on EBNX on ipoisland:

eBenX Inc. (EBNX):
eBenX, is a provider of software and solutions that allow businesses to manage and automate their health care plans for employees. The company's software allows businesses, primarily large ones, to integrate the current networks and technology systems, with the back-end systems of health care providers. The company's online service, eBenX, online allows it's customers, to access and view current transactions and information regarding their company's health plans. Key customers include, regional telephone company, Bell Atlantic, soft drink maker, PepsiCo, and multinational, G.E.

Key Competitors: Healtheon WebMD, Shared Medical Systems, McKesson HBOC, CareInsite

Financial Information:

1998 Sales: 10.1 million dollars

1998 Sales Growth: 42.7%

1998 Net Income: Loss of 1 million dollars

IPO Information:

Range: 10.50 to 12.50

Float: 5 million shares

Post-Offering Shares: 15 million

IPO Valuation (based on a price of 12.50): 187.5 million dollars

Underwriters:

Lead: BancBoston Robertson Stephens

Others: Warburg Dillon Read, Thomas Weisel Partners

Analysis: Although, Internet health care stocks, have not been as in favor as they once were, we are still high on this deal. The company unlike many recent Internet health care IPOs, doesn't operate in the content sector, instead the company operates in the less crowded but more lucrative back-office sector. In general back-office stocks, and those of back-office health care stocks, have performed well lately. Companies such as Jim Clark's Healtheon, and CareInsite, both had successful debuts. The IPO valuation is reasonable if not cheap, and the underwriting team is strong, led by one of our favorites, BancBoston Robertson Stephens. If this were any other week, this deal would be one investors would have marked down on their calendars in anticipation, instead it's one of the many strong yet not killer deals, this weak. Despite the crowded and strong weak, expect a very nice premium.

jim